Keyphrases
Clinical Outcomes
100%
Protein Expression
100%
Non-muscle Invasive Bladder Cancer (NMIBC)
100%
Cancer Association
100%
Genomic Changes
100%
Change Outcomes
100%
Sex Change
100%
Transcriptomic Changes
100%
STAG2
100%
Tumor
18%
Immunohistochemistry
18%
Urothelial Bladder Cancer
12%
Prognostic Indicator
12%
Bladder Recurrence
12%
Cancer Patients
6%
Published Data
6%
Disease-free Survival
6%
Aggressive Tumor
6%
Female Patients
6%
Treatment Decisions
6%
Low Risk
6%
Progression-free Survival
6%
Risk of Progression
6%
Significant Predictors
6%
Progression-free
6%
Conservative Treatment
6%
Molecular Characteristics
6%
RNA Sequencing (RNA-seq)
6%
Tumor Characteristics
6%
Copy number Variation
6%
Cancer-free
6%
Background mutations
6%
Disease-specific Survival
6%
Exome Sequencing
6%
Recurrence-free
6%
Progression Disease
6%
Early Bladder Cancer
6%
Expression Subtypes
6%
Medicine and Dentistry
Protein Expression
100%
Transcriptomics
100%
Non Muscle Invasive Bladder Cancer
100%
Neoplasm
71%
Bladder Cancer
42%
Immunohistochemistry
42%
Progression Free Survival
28%
Biological Marker
14%
Disease Free Survival
14%
Recurrent Disease
14%
Conservative Treatment
14%
Cancer Recurrence
14%
RNA Sequence
14%
Disease Specific Survival
14%
Exome Sequencing
14%
Biochemistry, Genetics and Molecular Biology
Genomics
100%
Protein Expression
100%
Transcriptomics
100%
Progression Free Survival
66%
Disease Free Survival
33%
RNA Sequence
33%
Exome Sequencing
33%
Disease Specific Survival
33%
Pharmacology, Toxicology and Pharmaceutical Science
Non Muscle Invasive Bladder Cancer
100%
Neoplasm
71%
Bladder Cancer
42%
Progression Free Survival
28%
Recurrent Disease
14%
Disease Free Survival
14%
Biological Marker
14%
Cancer Recurrence
14%
RNA-Sequencing
14%
Disease Specific Survival
14%